Impact of age on markers of HIV-1 disease

Author： Pirrone Vanessa   Libon David J   Sell Christian   Lerner Chad A   Nonnemacher Michael R   Wigdahl Brian  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.8, Iss.1, 2013-01, pp. : 81-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV Disease and Advanced Age: An Increasing Therapeutic Challenge

By Manfredi R.  

Drugs & Aging, Vol. 19, Iss. 9, 2002-01 ,pp. : 647-669

Adis International

Access to resources Recommend Favorite

Association between Self‐Reported Adherence to HIV Therapy and Disease Markers

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 4, 2002-12 ,pp. : 315-319

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of nevirapine in the treatment of HIV-1 disease

By Fumero Emilio   Podzamczer Daniel  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 2065-2078

Informa Healthcare

Access to resources Recommend Favorite

Phospholipid Analogs Against HIV-1 Infection and Disease

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1441-1451

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of genetic variation of HIV-1 on drug resistance development

By Snoeck Joke   Vandamme Anne-Mieke   Camacho Ricardo Jorge  

Future Virology, Vol. 2, Iss. 3, 2007-05 ,pp. : 303-310

Future Medicine

Access to resources Recommend Favorite